News
Janssen submits marketing application for talquetamab
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) has announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) has announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA).